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ABSTRACT  
A simple, precise, accurate, specific RP-HPLC method developed for sugammadex in bulk and simulated mixture. Chromatographic separation is 
achieved by C18 column (250 x 4.6 mm, 5µ) in isocratic mode. The optimized mobile phase consists of acetonitrile and double d istilled water in 
ratio of 20:80%v/v at a flow rate of 0.5mL/min and sugammadex was monitored at 210nm. Retention time of the drug was found to be 
3.39min. The linearity obtained in range of 50 – 250 µg/mL.  %RSD mean for precision and %Recovery mean of the sugammadex were found to 
be 0.63 and 99.04% - 99.84% respectively. Stability indicating nature of RP-HPLC method was established by applying the degradation 
condition. The results indicate that developed RP-HPLC method would be suitable for estimation of drug in presence of degradant product. The 
above developed method was validated according to ICH guideline. 
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INTRODUCTION   
Sugammadex is a selective relaxant binding agent, which is a 
modified gamma cyclodextrin. The full chemical name of 
drug is 6-per-deoxy-6-per-(2-carboxyethyl) thio-γ-
cyclodextrin, sodium salt. Due to its complex structure (as 
shown in fig 1.1), extreme polarity and good water solubility 
indicated for reversal of neuromuscular blockade induced by 
vecuronium bromide and rocuronium bromide during 
surgery in adults. Vecuronium bromide and rocuronium 
bromide are neuromuscular blocking medications that cause 
temporary paralysis and are especially useful for ventilation, 
general anesthesia, or tracheal intubation that patients may 
require for surgery. Sugammadex provides a new treatment 
option to reverse the effects of those medications and 
possibly help patients recover sooner post-surgery. 
Sugammadex (Bridion) was approved by the United States 
FDA on December 15, 2015. [1,2] 
This study aimed to validate the developed HPLC method for 
estimation of sugammadex sodium drug as per the ICH 
Guideline. Literature review suggest some UHPLC/TMS[3], 
HPLC/TMS[4], UV[5] spectroscopic method. After doing study 
in recent research work, it was found that the present 
research work has some advantages like its isocratic mobile 
phase, less run time, simple and economical. While literature 
review shows gradient mobile phase.  
                               
 
Fig.1.1 Sugammadex structure [6] 
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MATERIAL AND METHOD 
Sugammadex drug was obtained as a gift sample from Zydus 
Cadila, Ahemdabad, Gujarat. HPLC grade Acetonitrile was 
purchase from Astron Chemicals, Ahmedabad. Double 
Distilled Water was prepared in lab. 
Instrumentation: 
Shimadzu HPLC System Equipped with UV Detector, UV-VIS 
Spectrophotometer, pH meter and electronic balance also 
used in this study. 
Chromatographic Condition: 
Analytical Technologies Limited C18 column (4.6mm x 
250mm, 5µm) used as stationary phase. Acetonitrile and 
Double distilled water in the ratio of 20:80 (v/v) was used as 
mobile phase. Flow rate of 0.5 mL/min at Detection 
wavelength of 210 nm under reverse phase condition by UV 
detector. Injection volume of 20µL with run time of 10 
minutes. Water was used as diluent.  
Preparation of Standard stock solution: 
Weighed accurately about 10 mg of Sugammadex into 10 mL 
volumetric flask and make up the volume with water. 
Further, Dilute 1mL of resulting solution in 10mL of 
volumetric flask with water.  
Preparation of test Stock Solution (Simulated Mixture): 
Simulated formulation was prepared by accurately weighed 
10mg sugammadex and dilute it with water as condition in 
injection.[7] 
Method Validation 
The developed analytical method was further subjected to 
validation in accordance to the current ICH guidelines. The 
evaluated parameters like system suitability, specificity, 
linearity, accuracy, precision, accuracy, limit of detection, 
limit of quantification, ruggedness and robustness.[3-5,8] 
Specificity: Specificity is one of the significant feature of 
HPLC. It generate signals free from interference. Its 
capability to measure precisely an analyte in the presence of 
interferences that may be expected to be present in the 
sample. Typically these might be degradants, matrix, 
impurity. Identification tests should be able to differentiate 
compound of closely related structure which are expected to 
be present. Purity test ensures that the analytical procedure 
performed allows an accurate statement of content of the 
impurity of an analyte. Significance of assay is to arrive at an 
accurate result, this permit true report on the content or 
potency of analyte in a sample.[9] 
System Suitability: It is to prove that system is working 
ideally before the analysis on HPLC analyzer or any other 
system. SST required to done before every sample analysis. 
The System Suitability Testing (SST) limits should conform 
to the guideline provided by Center for Drug Evaluation and 
Research (CDER), International Conference on 
Harmonization (ICH). There is some parameter which can be 
checked using the SST. Such as retention time, repeatability, 
plate number, tailing factor, column efficiency, resolution, 
plate number, signal-to-noise ratio, pressure, etc. The SST 
shows that the requirements are met easily when the system 
is functioning perfectly and fail if there is a problem.[9,10] 
Linearity and Range: Linearity is capable to procure test 
results, which are directly proportional to the concentration 
of analyte in the sample. It can be analyzed by performing 
single measurements at several analyte concentration. The 
data is then processed using a linear least square regression. 
The resulting plot intercept, slop and correlation coefficient 
provide the desired information on linearity.[9]  Linearity is 
performed by adding accurate quantity of stock solution of 
sugammadex and volume adjusted to 10mL to set final 
concentration of 50, 100, 150, 200, and 250 µg/mL (Table 3 
and Fig. 3).  
Precision: Precision of an analytical method represents the 
closeness of individual measurements to each other under 
similar analytical condition and it is divided in three 
categories. The ICH guideline suggest that repeatability 
should be assessed using a minimum of 9 determination 
covering the specified range for the procedure 
(3concentration/ 3replicates each) or a minimum of 6 
determinations at 100% of the test concentration.[9] 
 Intraday Precision: It can be defined as within-day 
precision and performed by 3 replicates at 3 different 
concentrations (50, 150, 250 µg/mL) of sugammadex 
within a day as shown in table 5. 
 Inter-day Precision: It can also be referred to as 
between-day precision. It is determined by 3 replicates 
at 3 different concentrations (50, 150, 250 µg/mL) of 
sugammadex on different days as shown in table 6.      
 Repeatability: Precision under same analyst, same 
operating condition over short period of time. It was 
performed by 6 replicates of 100 µg/mL concentration. 
Accuracy: Accuracy is a measure of closeness of 
experimental value to the actual value of the substance. 
It is one of the most important parameters of an 
analytical method. It can also be defined as percent 
recovery of known amounts of drug added to a 
sample.[9,11] There are three way to determine 
accuracy: 
 Recovery of analyte spiked into blank matrix 
 Comparison to a reference standard 
 Standard addition of the analyte  
LOD: Limit of detection is determined by the analysis of 
samples with known concentration of drug and by 
establishing that minimum level at which the analyte can 
detected, but not necessarily quantitated as precise value. 
LOD is generally expressed in the concentration of analyte in 
the sample(ppm). A number of approaches are 
recommended by the ICH for determining the detection limit 
of sample, depending on nature of analyte, suitability of the 
method and instrument used for analysis. The acceptable 
approaches are signal to noise ratio, Standard deviation of 
the slope of the linearity plot, Visual evaluation, standard 
deviation of response.[9]  The formula for calculating LOD 
=         
LOQ: Limit of quantification is expressed as least 
concentration of analyte in a sample which is estimated with 
appropriate accuracy and precision under the affirmed 
experimental conditions. The formula for calculating LOQ is 
[9] 
LOQ = 10     
  = Standard deviation of response 
S = Mean of slopes of the of calibration curves.  
Robustness: It can be described as the ability of an 
analytical method to remain unaffected by small but 
deliberate variation in method parameters. The capability to 
reproduce the analytical method under different 
circumstances without the occurrence of unforeseen 
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differences in the obtained result. The variable method 
parameters in HPLC technique may involves pH, flow rate, 
column temperature, mobile phase composition, solvents 
grades, detection wavelength and sample temperature. 
Study was carried out by varying the one parameter and 
keeping other one standard parameter constant. The test 
was originally introduced to avoid problem in inter-
laboratory studies and to identify the potential responsible 
factors. [12,14] The test are carried out by injecting standard 
solution of sugammadex by varying parameter as mention in 
table 8. It shows stability of method. 
Matrix Robustness: Robustness of the sample matrix is 
advantageous to consider and it is favorable to distinguish it 
from the selectivity. Different matrices can lead to different 
matrix effects.[12,14] 
Ruggedness: It can be explained as the degree of 
reproducibility of sample results obtain under a variety of 
normal test condition like different instrument, different 
analyst, different laboratories, different days, different 
elapsed assay times, etc. ruggedness shows stability of 
method.[12,14] 
RESULT AND DISCUSSION 
Specificity 
The specificity of the method (analytical) for the assay of 
sugammadex is demonstrated by injecting solution into the 
HPLC system. 
 Diluent as a Blank (Figure 2) 
 Standard Solution of 100µg/mL Sugammadex (Figure 
3) 
 Test Solution (simulated mixture of sugammadex- 
Figure 4) 
 
Figure 2 Chromatogram of blank water 
 
Fig.3 Chromatogram of Simulated Mixture Sugammadex 
 
Fig.4 Chromatogram of Standard Sugammadex 
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Table1: Specificity of sugammadex 
Sr. no. Sample Name Analyte Name Specificity 
1 Blank No peak - 
2 Standard Sugammadex Specific 
3 Test Sugammadex Specific 
 
The method is considered to be specific as no peak was 
observed at the retention time of sugammadex in blank. 
(Fig.2).  
 
System Suitability  
Parameter were monitored by preparing 100µg/mL 
standard solution of Sugammadex and the solution were 
injected into three replicates and measure parameter like 
retention time, theoretical plate, peak tailing. Then calculate 
%RSD and data shows that the system functioning correctly 
as %RSD observed within acceptable limit (table 2). 
 
 
 
Table 2: System suitability data of sugammadex 
Parameters Mean (n=3) %RSD 
RT (min) 3.39  0.61  
Theoretical plates 14567  0.70  
Tailing Factor 1.87  1.47  
 
Linearity 
The linearity of sugammadex was determined by analyzing 
at 5 independent level. The range of 50 – 250 µg/mL 
(figure.5). The calibration curve of AUC of sugammadex vs 
concentration was plotted (figure.6) and correlation 
coefficient and regression line equation was calculated (table 
4). The method considered to be linear as the correlation 
coefficient was found within acceptance criteria. 
Table 3: Linearity data of sugammadex 
Conc. (µg/mL)  Mean Area  %RSD 
50 249.54 1.58 
100 434.73 1.02 
150 680.50 0.93 
200 912.40 1.77 
250 1154.17 0.82 
     
 
Fig.5: Linearity overlay Chromatogram of sugammadex   
 
 
 
Fig.6: Calibration curve of sugammadex 
Table 4. Regression data analysis RP-HPLC method. 
Parameters Sugammadex 
Wavelength 210nm 
Range 50 -250 µg/mL 
Regression Equation y = 4.5739x + 0.1931 
Slop (m) 4.5739 
Intercept (c) 0.1931 
Correlation coefficient 0.9979 
 
 
y = 4.5739x + 0.1931 
R² = 0.9979 
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Precision 
It was determined at three different levels at 50, 150 and 
250 µg/mL and were analyzed at three different level. %RSD 
of repeatability was found to be 0.47. %RSD of intraday and 
interday precision is shown in table 5 and 6.  
Table 5: Intraday precision data of sugammadex 
Conc. (µg/mL) Mean Area (n=3) %RSD 
50 249.85 0.64 
150 680.89 0.24 
250 1153.23 1.01 
 
Table 6: Interday precision data of sugammadex 
Conc. (µg/mL) Mean Area (n=3) %RSD 
50 255.64 1.78 
150 687.55 0.87 
250 1136.30 0.35 
 
Accuracy 
Recovery study obtained by using standard addition method 
of pure standards at three different levels in 80%, 100%, 
120% to the sample in triplicate.[8] The spiked test solution 
was analysed according to the proposed procedure. Then 
calculate the average percent recovery was obtained as 
99.04%, 99.85%, 99.10% respectively (as shown in table 7).
 
 
Table 7: Accuracy table of sugammadex 
Spiked Level 
Amount Present in Mixture 
(µg/mL) 
Amount Added 
(µg/mL) 
Amount 
Recovered 
% Recovery 
80% 100 80 178.31 
99.04% 80% 100 80 178.05 
80% 100 80 178.44 
100% 100 100 198.92 
99.85% 100% 100 100 200.91 
100% 100 100 199.27 
120% 100 120 218.25 
99.10% 120% 100 120 217.79 
120% 100 120 218 
 
 
LOD and LOQ 
Limit of detection is the lowest quantity of analyte in a 
sample which can be detected but not necessarily 
quantitated as an exact value. LOQ is the lowest amount of 
analyte in the sample which can be quantitatively 
determined with suitable precision and accuracy. LOD and 
LOQ were calculated based on the linearity data was found 
to be 0.19 and 0.57 respectively. 
Robustness  
There replicate solution of sugammadex at 100µg/mL were 
analyzed as per changes in level of factor as mention in 
below table i.e. changes in mobile phase and flow rate 
0.5mL/min. Which were analyzed as per the alter 
chromatographic condition. 
   
Table 8: Robustness data of sugammadex 
Factor Level Change Mean area (n=3) % RSD 
Mobile phase 
Water:ACN::82:18 460.00 0.85 
Water:ACN::80:20 452.81 1.22 
Water:ACN::78:22 443.27 1.25 
Flow rate 
(mL/min) 
0.45 451.59 0.35 
0.5 452.14 0.61 
0.55 450.36 0.44 
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Ruggedness  
The tests were carried out by injecting standard solution of sugammadex by different analyst and different instrument (table 
8).[14]  And calculate the % RSD. 
Table 9: Ruggedness data of sugammadex 
Factor Level change Mean area % RSD 
Different Analyst 
Analyst-1 460.00 0.85 
Analyst-2 452.81 1.22 
Different Instrument 
Instrument-1 451.59 0.35 
Instrument-2 452.14 0.61 
 
Assay of Simulated Mixture 
Assay was performed by adding 10mg sugammadex and make it up to 10mL with water. Take 1mL of resulting solution and 
volume adjust to 10mL with diluent water to set final concentration of 100µg/mL. 
Table 10: Assay data of sugammadex. 
Sr. No 
% Drug Recovered 
(n = 6) 
Mean %Drug 
Recovered 
%RSD of Drug 
Recovered 
1 99.61  
99.42  0.68  
2 98.89  
3 98.54  
4 99.42  
5 100.51  
6 99.54  
 
 
Degradation Study 
The goal of the present study is to provide information about 
condition for stress testing and to establish the stability of 
drug substances and product. There is different condition to 
observed degradation of drug.  
Acid Degradation: Degradation in acidic condition was 
performed by adding 20% of 0.005M HCl at room 
temperature kept for 20 minutes in dark condition. The 
solution was neutralized with 0.005M NaOH. Volume 
adjusted to 10mL with diluent to set final concentration of 
100µg/mL. Chromatogram (Figure 7) revealed 9.54% drug 
degraded in acid hydrolysis. 
 
 
Figure 7: Acid degradation of sugammadex 
 
Alkali Degradation: Degradation in basic condition was 
performed by adding 20% of 0.005M NaOH at room 
temperature kept for 20 minutes in dark condition. The 
solution was neutralized by 0.005M HCl. And volume make 
up to 10mL with water to set final concentration of 
100µg/mL. Chromatogram (Figure 8) revealed 24.78% drug 
degraded in alkali hydrolysis. 
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Figure 8: Base degradation of sugammadex 
 
Oxidative degradation: Performed by adding 3% hydrogen 
peroxide at room temperature in dark. Volume adjusted to 
10mL with water to set final concentration(100µg/mL). It 
gives 18.88% drug degradation (Figure. 9 and Table 9).
 
 
Figure 9: Oxidative degradation of sugammadex 
Drug was not stable in photolytic degradation due to sugammadex is light sensitive drug. [12] 
Table 9: Degradation summary of sugammadex 
Degradation Type Stress Condition % Assay %Drug Degradation 
Controlled Sample As such 100% - 
Acid Hydrolysis 0.005M HCl 90.46% 9.54% 
Alkali Hydrolysis 0.005M NaOH 75.22% 24.78% 
Oxidative Degradation 3% H2O2 81.12 18.88% 
 
 
CONCLUSION: 
Sugammadex is selective relaxant binding. A simple, precise, 
specific, accurate, sensitive RP-HPLC method have been 
developed and validated. Accuracy was observed. In 
Concentration range of 50 – 250µg/mL with correlation 
coefficient. The mean assay of sugammadex simulated 
mixture was found to be 92.42%. The result of the study 
follows the protocol of ICH guideline.  The procedure 
described is suitable for the routine estimation of 
sugammadex.  
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